Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Gritstone bio (GRTS) stocks in Canada

Learn how to easily invest in Gritstone bio stocks.

Gritstone bio is a biotechnology business based in the US. Gritstone bio stocks (GRTS.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $8.3 – a decrease of 12.22% over the previous week. Gritstone bio employs 188 staff and has a trailing 12-month revenue of around $46.5 million.

How to buy shares in Gritstone bio

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – GRTS – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Gritstone bio stock price (NASDAQ:GRTS)

Use our graph to track the performance of GRTS stocks over time.

Gritstone bio shares at a glance

Information last updated 2022-01-17.
Latest market close$5.53
52-week range$6.00 - $35.20
50-day moving average $10.89
200-day moving average $9.68
Wall St. target price$19.67
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-1.07

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
Wealthsimple Trade
Finder Rating:
3.9 / 5
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
3.8 / 5
$4.99 - $9.99
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
4.1 / 5
Min. $1.00, Max. 0.5%
Stocks, Bonds, Options, ETFs, Currencies, Futures
CIBC Investor's Edge
Finder Rating:
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
Finder Rating:
4.2 / 5
$4.95 - $9.95
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get a $50 bonus when you open a new RRSP, TFSA or RESP and start pre-authorized contributions of $200+/month. Valid until March 1, 2022.

Compare up to 4 providers

Online stock trading

Is it a good time to buy Gritstone bio stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Gritstone bio price performance over time

Historical closes compared with the close of $5.53 from 2022-01-19

1 week (2022-01-13) -12.22%
1 month (2021-12-17) -59.66%
3 months (2021-10-20) -36.87%
6 months (2021-07-20) -30.35%
1 year (2021-01-20) -78.31%
2 years (2020-01-17) -50.76%
3 years (2019-01-18) 15.6
5 years (2017-01-16) N/A

Gritstone bio financials

Revenue TTM $46.5 million
Gross profit TTM $-84,606,000
Return on assets TTM -23.04%
Return on equity TTM -51.78%
Profit margin -155.87%
Book value $3.24
Market capitalisation $424.9 million

TTM: trailing 12 months

Gritstone bio share dividends

We're not expecting Gritstone bio to pay a dividend over the next 12 months.

Gritstone bio share price volatility

Over the last 12 months, Gritstone bio's shares have ranged in value from as little as $6 up to $35.2. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Gritstone bio's is 0.0036. This would suggest that Gritstone bio's shares are less volatile than average (for this exchange).

Gritstone bio overview

Gritstone bio, Inc. , a clinical-stage biotechnology company, engages in developing tumor-specific cancer immunotherapies to fight various cancer types and infectious diseases. Its lead product candidate is GRANITE, which is in Phase I/II clinical trial for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder and microsatellite stable, and colorectal cancers. The company is also developing SLATE, an off-the-shelf immunotherapy candidate for the treatment of common solid tumors, including metastatic non-small cell lung cancer, colorectal cancer, pancreatic cancer, and other mutation-positive tumors. Gritstone Oncology, Inc. has a strategic collaboration with bluebird bio, Inc. The company was formerly known as Gritstone Oncology, Inc.

Stocks similar to Gritstone bio

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site